Unjha Formulations
20.02
-20.02(-100.00%)
Market Cap₹9.00 Cr
PE Ratio8.63
IndustryHealthcare
Company Performance:
1D-100.00%
1M-100.00%
6M-100.00%
1Y-100.00%
5Y-100.00%
View Company Insightsright
More news about Unjha Formulations
01Oct 25
Unjha Formulations Appoints Siddharth Shah as Company Secretary and Compliance Officer
Unjha Formulations Limited has appointed Mr. Siddharth Shah as its new Company Secretary and Compliance Officer, effective October 1, 2025. The decision was made during a board meeting on the same date. Mr. Shah, an Associate Member of ICSI with membership number A67232, brings over five years of experience in compliance, insolvency, finance, taxation, and corporate laws. The appointment aligns with Section 203 of the Companies Act, 2013 and Regulation 6 of SEBI Listing Obligations.
 no imag found
06Aug 25
Unjha Formulations Reports Q1 Loss Amid Rising Expenses
Unjha Formulations Limited announced a net loss of Rs. 40.64 lakhs for the first quarter, compared to a profit of Rs. 50.76 lakhs in the same period last year. Total income decreased to Rs. 363.40 lakhs from Rs. 395.43 lakhs year-over-year, while total expenses rose to Rs. 325.81 lakhs from Rs. 272.54 lakhs. The company's Earnings Per Share (EPS) turned negative at Rs. 0.91, down from positive Rs. 1.56 in the previous year's quarter. Despite a 5.01% decrease in material costs and a 24.64% reduction in employee benefits expenses, other expenses increased by 76.79%, contributing to the overall loss.
 no imag found
Unjha Formulations
20.02
-20.02
(-100.00%)
1 Year Returns:-100.00%
Industry Peers
Sun Pharmaceutical
1,693.70
(+1.43%)
Divis Laboratories
6,441.00
(+2.47%)
Torrent Pharmaceuticals
4,147.30
(+1.54%)
Dr Reddys Laboratories
1,302.90
(+7.06%)
Lupin
2,374.80
(+2.90%)
Cipla
1,285.10
(+3.95%)
Zydus Life Science
954.00
(+2.59%)
Mankind Pharma
2,312.80
(+3.48%)
Aurobindo Pharma
1,443.00
(+1.53%)
Alkem Laboratories
5,540.50
(-1.54%)